BioSpace News Archive

Career Advice

Grace Under Fire: How to Respond to Tough Job Interview Questions

It’s one of the biggest sources of anxiety when you’re on the job market: being faced with tough interview questions that you aren’t quite sure how to answer.

October 22, 2018
·
3 min read
·
Editorial Staff
Drug Development

Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

Additional subgroup analysis shows subcutaneous formulation of vedolizumab achieves significantly higher clinical remission rates to placebo in anti-TNFα-naïve patients

October 22, 2018
·
13 min read
Drug Development

BerGenBio Announces Interim Biomarker and Phase II Clinical Data with Selective AXL Inhibitor Bemcentinib Presented at ESMO

Biomarker predicts clinical benefit rate of 70% and overall response rate of 40% in second line NSCLC

October 22, 2018
·
6 min read
Pharm Country

IAVI and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products for HIV

Collaboration to develop optimal combination of HIV-specific antibodies and ensure that cost is not a barrier to access

October 22, 2018
·
8 min read
Business

Anaeropharma Science Signs Collaborative Research Agreement with Chugai on Creation of Novel Oncology Drugs Using Bifidobacterium

Anaeropharma Science Inc. announced on October 22 that Anaeropharma Science and Chugai Pharmaceutical Co., Ltd. headquartered in Tokyo (hereinafter “Chugai”) have concluded a collaborative research agreement concerning the creation of novel oncology drugs utilizing characteristic features of Bifidobacterium longum through Anaeropharma’s proprietary platform technology, “in situ Delivery and Production System” (hereinafter “i-DPS”).

October 22, 2018
·
2 min read
Business

Vivior Chairman Receives Award for Outstanding Contributions to Refractive Surgery

Michael Mrochen, PhD, Chairman of the Board of Directors at Vivior, receives the Casebeer Award from the International Society of Refractive Surgery.

October 22, 2018
·
2 min read
Genetown

SeraCare Announces Launch of Expanded NTRK Reference Material Panel

An important new tool for labs seeking to detect NTRK gene fusions by next-generation sequencing

October 22, 2018
·
3 min read
FDA

Biohaven Receives Authorization to Proceed from FDA and Doses First Subject with BHV-3500, Third-Generation, Small Molecule CGRP-Receptor Antagonist

BHV-3500 is the first small molecule calcitonin gene-related peptide (CGRP) receptor antagonist to be administered in an intranasal (IN) formulation in human testing

October 22, 2018
·
7 min read
Drug Development

Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Durable Clinical Benefit in Previously Untreated Patients with MSI-H or dMMR Metastatic Colorectal Cancer

Combination showed 60% objective response rate (investigator-assessed)

October 22, 2018
·
35 min read
Drug Development

Genentech’s Tecentriq Plus Chemotherapy (Carboplatin and Abraxane) as an Initial Treatment Helped People With Advanced Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone

The Phase III IMpower130 study investigating the Tecentriq plus chemotherapy combination demonstrated a significant overall survival (OS) and progression-free survival (PFS) benefit

October 22, 2018
·
12 min read